telbivudine has been researched along with Co-infection in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayana, DA; Cai, Y; Ji, H; Jiang, Y; Li, C; Liu, M; Lv, P | 1 |
| Bonadies, G; Borgia, G; Borrelli, F; Buonomo, AR; Carleo, MA; Gentile, I; Portella, G | 1 |
| Arends, JE; Beilhartz, GL; de Jong, D; Götte, M; Hoepelman, AI; Nijhuis, M; Obikhod, A; Pingen, M; Schinazi, RF; Tao, S; van Maarseveen, NM; Wensing, AM | 1 |
3 other study(ies) available for telbivudine and Co-infection
| Article | Year |
|---|---|
Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Coinfection; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interleukin-1; Interleukin-10; Interleukin-2; Male; Middle Aged; Telbivudine; Thymidine; Young Adult | 2013 |
In vivo antiviral activity of telbivudine against HIV-1: a case report.
Topics: Acute Disease; Adenine; Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Immunocompromised Host; Male; Organophosphonates; Telbivudine; Thymidine; Treatment Outcome | 2013 |
Telbivudine exerts no antiviral activity against HIV-1 in vitro and in humans.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Cell Line; Coinfection; DNA, Viral; Drug Resistance, Viral; Genotype; HEK293 Cells; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; HIV-1; Humans; Male; Middle Aged; Nucleosides; Phenotype; Pyrimidinones; RNA, Viral; Telbivudine; Thymidine; Viral Load | 2011 |